Enclosure with augmented airflow to decrease risk of exposure to aerosolized pathogens including coronavirus during endotracheal intubation. Can the reduction in aerosolized particles be quantified?

Publisher: Arnette-Blackwell Country of Publication: France NLM ID: 9206575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-9592 (Electronic) Linking ISSN: 11555645 NLM ISO Abbreviation: Paediatr Anaesth Subsets: MEDLINE

Original Publication: Paris, France : Arnette-Blackwell, c1991-

Betacoronavirus*; Aerosols/*chemistry ; Airway Management/*methods ; Coronavirus Infections/*prevention & control ; Intubation, Intratracheal/*methods ; Pandemics/*prevention & control ; Pneumonia, Viral/*prevention & control; Anesthesia, Inhalation/methods ; COVID-19 ; Humans ; Particulate Matter ; Pulmonary Ventilation ; SARS-CoV-2 ; Suction

Introduction: As the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) has impacted hospital routines in recent weeks, recommendations to reduce healthcare worker infections are being developed.
Methods: We report preliminary experience with the efficacy of an enclosure with augmented airflow to decrease the risk of exposure to aerosolized pathogens during airway management including endotracheal intubation. A particle generator was used to test the efficacy of the reduction of aerosolized particles by measuring their concentration within the enclosure and in the environment.
Results: No reduction in the concentration of aerosolized particles was noted with the enclosure flap open, whether the interior suction was on or off. However, with the enclosure closed and no augmented airflow (suction off), the particle concentration decreased to 1.2% of baseline. The concentration decreased even further, to 0.8% of baseline with the enclosure closed with augmented airflow (suction on).
Discussion: Aerosolized particulate contamination in the operating room can be decreased using a clear plastic enclosure with minimal openings and augmented airflow. This may serve to decrease the exposure of healthcare providers to aerosolized pathogens.
(© 2020 John Wiley & Sons Ltd.)

Am J Infect Control. 2005 Mar;33(2):114-21. (PMID: 15761412)
J Occup Environ Hyg. 2019 Jul;16(7):489-497. (PMID: 31107187)
Can J Anaesth. 2020 Jul;67(7):902-904. (PMID: 32246431)
Paediatr Anaesth. 2020 Aug;30(8):900-904. (PMID: 32464695)
Br J Anaesth. 2020 Feb 22;:. (PMID: 32098647)
Br J Anaesth. 2003 Jun;90(6):715-8. (PMID: 12765882)
PLoS One. 2012;7(4):e35797. (PMID: 22563403)
N Engl J Med. 2020 May 14;382(20):1957-1958. (PMID: 32243118)
Infect Dis Clin North Am. 2010 Sep;24(3):619-38. (PMID: 20674795)
Crit Care Med. 2010 Aug;38(8 Suppl):S306-14. (PMID: 20647788)
Anesth Analg. 2020 Jul;131(1):37-42. (PMID: 32217947)

Keywords: anesthesia; coronavirus; infection control; intubation; pandemic

0 (Aerosols)
0 (Particulate Matter)

Date Created: 20200529 Date Completed: 20201001 Latest Revision: 20220727

20240628

PMC7283870

10.1111/pan.13934

32464695